Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:682-688
Published online before print January 22, 2008, doi: 10.1161/HYPERTENSIONAHA.107.101444
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/3/682    most recent
HYPERTENSIONAHA.107.101444v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feldt, S.
Right arrow Articles by Muller, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feldt, S.
Right arrow Articles by Muller, D. N.
Related Collections
Right arrow ACE/Angiotension receptors

(Hypertension. 2008;51:682.)
© 2008 American Heart Association, Inc.


Original Articles

Prorenin and Renin-Induced Extracellular Signal-Regulated Kinase 1/2 Activation in Monocytes Is Not Blocked by Aliskiren or the Handle-Region Peptide

Sandra Feldt; Wendy W. Batenburg; Istvan Mazak; Ulrike Maschke; Maren Wellner; Heda Kvakan; Ralf Dechend; Anette Fiebeler; Celine Burckle; Aurelie Contrepas; A.H. Jan Danser; Michael Bader; Genevieve Nguyen; Friedrich C. Luft; Dominik N. Muller

From the Medical Faculty of the Charité (S.F., H.K., R.D., A.F., F.C.L., D.N.M.), Experimental and Clinical Research Center, Franz Volhard Clinic and HELIOS Klinikum, Berlin-Buch, Germany; Max-Delbrück-Center for Molecular Medicine (I.M., U.M., M.W., C.B., M.B., F.C.L., D.N.M.), Berlin-Buch, Germany; Institut National de la Santé et de la Recherche Médicale (A.C., G.N.), Unit 833, and Collège de France, Chaire de Médecine Expérimentale, Paris, France; and the Department of Pharmacology (W.W.B., A.H.J.D.), Erasmus MC, Rotterdam, The Netherlands.

Correspondence to Dominik N. Muller, Experimental and Clinical Research Center, Lindenberger Weg 80, 13125 Berlin, Germany. E-mail dominik.mueller{at}mdc-berlin.de

The recently cloned (pro)renin receptor [(P)RR] mediates renin-stimulated cellular effects by activating mitogen-activated protein kinases and promotes nonproteolytic prorenin activation. In vivo, (P)RR is said to be blocked with a peptide consisting of 10 amino acids from the prorenin prosegment called the "handle-region" peptide (HRP). We tested whether human prorenin and renin induce extracellular signal-regulated kinase (ERK) 1/2 activation and whether the direct renin inhibitor aliskiren or the HRP inhibits the receptor. We detected the (P)RR mRNA and protein in isolated human monocytes and in U937 monocytes. In U937 cells, we found that both human renin and prorenin induced a long-lasting ERK 1/2 phosphorylation despite angiotensin II type 1 and 2 receptor blockade. In contrast to angiotensin II-ERK signaling, renin and prorenin signaling did not involve the epidermal growth factor receptor. A mitogen-activated protein kinase kinase 1/2 inhibitor inhibited both renin and prorenin-induced ERK 1/2 phosphorylation. Neither aliskiren nor HRP inhibited binding of 125I-renin or 125I-prorenin to (P)RR. Aliskiren did not inhibit renin and prorenin-induced ERK 1/2 phosphorylation and kinase activity. Fluorescence-activated cell sorter analysis showed that, although fluorescein isothiocyanate-labeled HRP bound to U937 cells, HRP did not inhibit renin or prorenin-induced ERK 1/2 activation. In conclusion, prorenin and renin-induced ERK 1/2 activation are independent of angiotensin II. The signal transduction is different from that evoked by angiotensin II. Aliskiren has no (P)RR blocking effect and did not inhibit ERK 1/2 phosphorylation or kinase activity. Finally, we found no evidence that HRP affects renin or prorenin binding and signaling.


Key Words: renin • prorenin • (pro)renin receptor • aliskiren • signal transduction




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Ino, C. Kojima, M. Osaka, K. Nitta, and M. Yoshida
Dynamic Observation of Mechanically-Injured Mouse Femoral Artery Reveals an Antiinflammatory Effect of Renin Inhibitor
Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1858 - 1863.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
Y. Nagai, A. Ichihara, D. Nakano, S. Kimura, N. Pelisch, Y. Fujisawa, H. Hitomi, N. Hosomi, H. Kiyomoto, M. Kohno, et al.
Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats
Exp Physiol, September 1, 2009; 94(9): 1016 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Contrepas, J. Walker, A. Koulakoff, K. J. Franek, F. Qadri, C. Giaume, P. Corvol, C. E. Schwartz, and G. Nguyen
A role of the (pro)renin receptor in neuronal cell differentiation
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R250 - R257.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Advani, D. J. Kelly, A. J. Cox, K. E. White, S. L. Advani, K. Thai, K. A. Connelly, D. Yuen, J. Trogadis, A. M. Herzenberg, et al.
The (Pro)Renin Receptor: Site-Specific and Functional Linkage to the Vacuolar H+-ATPase in the Kidney
Hypertension, August 1, 2009; 54(2): 261 - 269.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Satofuka, A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, A. Fukamizu, K. Tsubota, H. Itoh, Y. Oike, and S. Ishida
(Pro)renin Receptor-Mediated Signal Transduction and Tissue Renin-Angiotensin System Contribute to Diabetes-Induced Retinal Inflammation
Diabetes, July 1, 2009; 58(7): 1625 - 1633.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Mercure, G. Prescott, M.-J. Lacombe, D. W. Silversides, and T. L. Reudelhuber
Chronic Increases in Circulating Prorenin Are not Associated With Renal or Cardiac Pathologies
Hypertension, June 1, 2009; 53(6): 1062 - 1069.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Cousin, D. Bracquart, A. Contrepas, P. Corvol, L. Muller, and G. Nguyen
Soluble Form of the (Pro)Renin Receptor Generated by Intracellular Cleavage by Furin Is Secreted in Plasma
Hypertension, June 1, 2009; 53(6): 1077 - 1082.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Gratze, M. Boschmann, R. Dechend, F. Qadri, J. Malchow, S. Graeske, S. Engeli, J. Janke, J. Springer, A. Contrepas, et al.
Energy Metabolism in Human Renin-Gene Transgenic Rats: Does Renin Contribute to Obesity?
Hypertension, March 1, 2009; 53(3): 516 - 523.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Questions & Answers -- Understanding the Renin System
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 247 - 249.
[PDF]


Home page
DiabetesHome page
V. P. Singh, B. Le, R. Khode, K. M. Baker, and R. Kumar
Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis
Diabetes, December 1, 2008; 57(12): 3297 - 3306.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
H. Krum
Role of renin in heart failure and therapeutic potential of direct renin inhibition
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 177 - 180.
[PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
W. W Batenburg and A. J. Danser
Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskiren
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 181 - 184.
[PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Susic, X. Zhou, E. D. Frohlich, H. Lippton, and M. Knight
Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1117 - H1121.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. J. Danser and G. Nguyen
Spotlight on Renin: The Renin Academy Summit: advancing the understanding of renin science
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 119 - 123.
[PDF]


Home page
Exp PhysiolHome page
G. Nguyen and A. H. J. Danser
Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents
Exp Physiol, May 1, 2008; 93(5): 557 - 563.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Campbell
Critical Review of Prorenin and (Pro)renin Receptor Research
Hypertension, May 1, 2008; 51(5): 1259 - 1264.
[Full Text] [PDF]


Home page
HypertensionHome page
D. N. Muller, B. Klanke, S. Feldt, N. Cordasic, A. Hartner, R. E. Schmieder, F. C. Luft, and K. F. Hilgers
(Pro)Renin Receptor Peptide Inhibitor "Handle-Region" Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats
Hypertension, March 1, 2008; 51(3): 676 - 681.
[Abstract] [Full Text] [PDF]